← Leaderboards
Robert Charles Speth
Mellon Pitts Corporation (Mpc Corp)
$1,075,660
Attributed
$1,261,860
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $436K · FY2009–25$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,261,860 · 4
By mechanism
R15$808,430 · 2
R21$453,430 · 1
P41$0 · 1
Top collaborators
- Lisa Suzanne Robison1 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsAlzheimer&AposBrainPhysiologicalCardiovascular SystemLigandsReceptorFutureKidneyAmericanInhibitor/AntagonistRadiolabeledAngiotensin ReceptorBinding (Molecular Function)EnzymesHypertensionAffectComplementAgtr2 GeneAngiotensin IiCardiovascular DiseasesAffinityNeuronsNovel Therapeutics
Grant awards (14)
Comparison of Tirzepatide, Retatrutide, and Crocetin, for Mitigation of Alzheimer's-like Pathology in a Mouse Model of Alzheimerâs Disease$372,400
R15 · FY2025 · AG · contact PI
Development of a radioligand for assay of angiotensin-converting enzyme-2(ACE-2)$393,677
R15 · FY2013 · HL · contact PI
Development of a radioligand for assay of angiotensin-converting enzyme-2(ACE-2)$20,475
R15 · FY2013 · HL · contact PI
Development of a radioligand for assay of angiotensin-converting enzyme-2(ACE-2)$10,939
R15 · FY2013 · HL · contact PI
Development of a radioligand for assay of angiotensin-converting enzyme-2(ACE-2)$10,939
R15 · FY2013 · HL · contact PI
Brain specific non-AT1, non-AT2 angiotensin binding site$172,199
R21 · FY2010 · HL · contact PI
Brain specific non-AT1, non-AT2 angiotensin binding site$46,099
R21 · FY2010 · HL · contact PI
Brain specific non-AT1, non-AT2 angiotensin binding site$15,611
R21 · FY2010 · HL · contact PI
Brain specific non-AT1, non-AT2 angiotensin binding site$15,611
R21 · FY2010 · HL · contact PI
Brain specific non-AT1, non-AT2 angiotensin binding site$6,866
R21 · FY2010 · HL · contact PI
Brain specific non-AT1, non-AT2 angiotensin binding site$197,044
R21 · FY2009 · HL · contact PI
ANGIOTENSIN II RECEPTORS &OTHER MEMBERS OF G PROTEIN LINKED RECEPTOR FAMILY$0
P41 · FY2002 · RR
ANGIOTENSIN II RECEPTORS &OTHER MEMBERS OF G PROTEIN LINKED RECEPTOR FAMILY$0
P41 · FY2002 · RR
ANGIOTENSIN II RECEPTORS &OTHER MEMBERS OF G PROTEIN LINKED RECEPTOR FAMILY$0
P41 · FY2001 · RR